We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study.
- Authors
Klimek, L; Willers, J; Hammann-Haenni, A; Pfaar, O; Stocker, H; Mueller, P; Renner, W A; Bachmann, M F
- Abstract
Allergic symptoms are generally caused by exposure to substances to which people have become sensitized. Associated with this is an 'unbalanced' Th1/Th2 immune response with T cell responses skewed towards the production of Th2 cytokines, IL-4, 5, and 13 and high levels of IgE antibodies. Current immune modulating therapies require the use of allergens, carrying the risk to induce potentially severe allergic reactions.
- Publication
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2011, Vol 41, Issue 9, p1305
- ISSN
1365-2222
- Publication type
Journal Article
- DOI
10.1111/j.1365-2222.2011.03783.x